Medicover AB (publ)
MCVEY · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $597 | $578 | $556 | $528 |
| % Growth | 3.2% | 4% | 5.3% | – |
| Cost of Goods Sold | $455 | $445 | $435 | $415 |
| Gross Profit | $142 | $133 | $121 | $113 |
| % Margin | 23.8% | 23% | 21.7% | 21.4% |
| R&D Expenses | $0 | $0 | $7 | $0 |
| G&A Expenses | $73 | $70 | $71 | $82 |
| SG&A Expenses | $100 | $97 | $97 | $106 |
| Sales & Mktg Exp. | $27 | $27 | $27 | $25 |
| Other Operating Expenses | $0 | $0 | -$7 | $0 |
| Operating Expenses | $100 | $97 | $97 | $106 |
| Operating Income | $42 | $36 | $23 | $7 |
| % Margin | 7% | 6.2% | 4.2% | 1.3% |
| Other Income/Exp. Net | -$17 | -$10 | -$13 | -$14 |
| Pre-Tax Income | $25 | $26 | $10 | -$7 |
| Tax Expense | $7 | $7 | $3 | -$2 |
| Net Income | $19 | $20 | $9 | -$4 |
| % Margin | 3.2% | 3.5% | 1.5% | -0.8% |
| EPS | 0.13 | 0.13 | 0.057 | -0.029 |
| % Growth | 0% | 126.5% | 295.9% | – |
| EPS Diluted | 0.13 | 0.13 | 0.057 | -0.03 |
| Weighted Avg Shares Out | 151 | 150 | 150 | 150 |
| Weighted Avg Shares Out Dil | 151 | 151 | 150 | 150 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $2 |
| Interest Expense | $17 | $15 | $15 | $17 |
| Depreciation & Amortization | $55 | $51 | $50 | $67 |
| EBITDA | $96 | $92 | $75 | $77 |
| % Margin | 16.1% | 15.9% | 13.6% | 14.7% |